A Pilot Study for the Treatment of Iris Neovascularization With Macugen

NCT00295828 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Iris Neovascularization
Diabetic Retinopathy

Interventions

OTHER: Pegaptanib Sodium Injection/Panretinal Photocoagulation
PROCEDURE: Panretinal Photocoagulation (PRP)

Sponsor

Hermann Eye Center

Collaborators

[object Object]